Fundz

CytoReason Secures $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific to Scale Its AI Disease Models and Establish US Hub in Cambridge, Massachusetts

PRIVATEJul 17, 2024

Amount Raised

$80 Million

Round Type

Funding Round

BiotechnologyAnalytics

Investors

Thermo Fisher ScientificPfizerNvidiaOur Crowd

Description

CytoReason has secured an aggregated $80 million from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific. The investment will be used to expand the application of its models into additional indications, grow its proprietary molecular and clinical data, and establish an office in Cambridge, Massachusetts later this year.

Quick answer

CytoReason raised $80 Million in a Funding Round round, dated July 17, 2024. Investors: Thermo Fisher Scientific, Pfizer, Nvidia and Our Crowd.

How much did CytoReason raise?
CytoReason raised $80 Million in a Funding Round round on July 17, 2024.
Who invested in CytoReason?
Thermo Fisher Scientific, Pfizer, Nvidia and Our Crowd are named as investors in this round.
What does CytoReason do?
CytoReason is a tech company transforming biopharma’s decision-making from trial and error to data-driven using an AI Platform of computational disease models.
Who are the decision-makers at CytoReason?
Fundz holds 1 contact at CytoReason. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Analytics and Biotechnology around the same time

Companies in the same sectors as CytoReason that raised within 45 days of this round, from Fundz verified event records.

  • Reliant AI raised $11M (Seed) on August 20, 2024.
  • Rivia raised $3.2M (Seed) on June 12, 2024.
  • i'SUPPLY raised $2.5M (Pre-Series A) on June 11, 2024.
  • RevolKa raised $1.7M (Series A) on August 30, 2024.
  • Okami Medical raised $19M on August 30, 2024.
  • Pulmotect raised $10M on August 30, 2024.

Who to call at CytoReason, and when

A new round usually means CytoReason is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CytoReason raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CytoReason, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CytoReason. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CytoReason

About

CytoReason is a tech company transforming biopharma’s decision-making from trial and error to data-driven using an AI Platform of computational disease models. With its extensive database of public and proprietary data, the company maps human diseases – tissue by tissue and cell by cell. Researchers of all levels rely on CytoReason’s technology to make data-driven decisions across the drug development life cycle. Scientists can identify potential targets, prioritize indications, and stratify patient populations. Program leaders can compare drugs across multiple diseases or multiple drugs within a single disease. C-level executives can gain valuable tools to manage and optimize entire drug portfolios.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CytoReason raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for CytoReason's next move

See what Strategic adds

CytoReason raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.